Acacia Research Corp (ACTG): Frank E. Iii Walsh , director of Acacia Research Corp purchased 20,000 shares on May 19, 2016. The Insider buying transaction was reported by the company on May 23, 2016 to the Securities and Exchange Commission. The shares were purchased at $4.59 per share for a total value of $91,775.80 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on May 20, 2016, G Louis Iii Graziadio (director) purchased 98,887 shares at $4.59 per share price.On May 19, 2016, Frank E. Iii Walsh (director) purchased 40,000 shares at $4.64 per share price.Also, On Apr 27, 2016, Marvin E Key (CEO) purchased 55,000 shares at $4.15 per share price.On Apr 27, 2016, Frank E Iii Walsh (director) purchased 35,000 shares at $4.13 per share price.
Acacia Research Corp: On Friday, May 20, 2016 heightened volatility was witnessed in Acacia Research Corp which led to swings in the share price. The shares opened for trading at $4.71 and hit $5.02 on the upside , eventually ending the session at $4.98, with a gain of 7.33% or 0.34 points. The heightened volatility saw the trading volume jump to 7,86,521 shares. The 52-week high of the share price is $10.69 and the company has a market cap of $250,982 M . The 52-week low of the share price is at $2.82.
Company has been under the radar of several Street Analysts.Acacia Research Corp is Upgraded by Northland Capital to Outperform. Earlier the firm had a rating of Market Perform on the company shares. The Rating was issued on May 23, 2016.
Acacia Research Corporation is a holding company. The Company through its subsidiaries engaged in patent investment prosecution licensing and enforcement activities. The Company’s subsidiaries partner with inventors and patent owners for patented inventions. The Company’s subsidiaries generate revenues from the granting of intellectual property rights for the use of patented technologies that its subsidiaries control or own. Its subsidiaries own or control the rights to multiple patent portfolios which include the United States patents and certain foreign counterparts covering technologies used in a variety of industries. The Company is engaged in licensing and enforcing patented technologies and has licensed over 1430 license agreements across 181 of its patent portfolio licensing and enforcement programs.